Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Bioverge

Founders Neil Littman Rick Gibb

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 51
Average round size
info
The average size of a deal this fund participated in
$2M
Portfolio companies 35
Rounds per year 6.38
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.25
Exits 1
Key employees 1
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical Device
  • Medical
Summary

In 2016 was created Bioverge, which is appeared as Corporate Investor.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Bioverge, startups are often financed by Venture University, VU Venture Partners, Thomas Glocer. The meaningful sponsors for the fund in investment in the same round are Thiel Capital, Techammer, Phil Libin.

We can highlight the next thriving fund investment areas, such as Artificial Intelligence, Therapeutics. Among the most popular portfolio startups of the fund, we may highlight OccamzRazor. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.

The fund was created by Neil Littman, Rick Gibb.

The important activity for fund was in 2019. The fund is generally included in 2-6 deals every year. The usual things for fund are deals in the range of 1 - 5 millions dollars.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Bioverge:
Typical Co-investors
Bioverge is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Bioverge:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Dijian Trading China, Guangdong, Tianjin
Essential Investment Partners -
French Public Bank of Investment -
G Street Capital China, Guangdong, Shenzhen
High Ground Capital Beijing, Beijing, China
Hunch Ventures Delhi, India, New Delhi
Iroquois Capital Nashville, Tennessee, United States
MAD Ventures GmbH Austria, Innsbruck, Tirol
Osmington Canada, Ontario, Toronto
Peak Opportunity Partners New York, New York, United States
Sand 9 Cambridge, Massachusetts, United States
Sandvine Canada, Ontario, Waterloo
Silver Lake California, Menlo Park, United States
SummitVision Capital, LLC California, San Francisco, United States
TD Veen Norway, Rogaland, Stavanger
The Japan Research Institute Japan, Setagaya
Tofino Capital District of Columbia, United States, Washington
Zhejiang Lusheng Shipen Keji Co., Ltd China, Ningbo, Zhejiang

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

My Diabetes Tutor

27 Jul 2023 -

Modulo Bio

Biotechnology
Medical
Product Research
$8M01 Jun 2023 San Diego, California, United States

Eigen Therapeutics

$7M08 Dec 2022 -

GigaMune

Biotechnology
Medical
01 Nov 2022 South San Francisco, California, United States

Notable Labs

Biotechnology
Health Care
01 Jul 2022 California, United States

Foresight Mental Health

Health Care
Medical
23 Jun 2022 Berkeley, California, United States

Octant Bio

Biotechnology
Life Science
$80M28 Apr 2022 Los Angeles, California, United States

Alto Neuroscience

Artificial Intelligence
Biopharma
Neuroscience
18 Mar 2022 Los Altos, California, United States

Bionaut Labs

Biopharma
Biotechnology
Health Care
Therapeutics
16 Mar 2022 Los Angeles, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Bioverge?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 51
Average round size 2M
Rounds per year 6.38
Peak activity year 2020
Lead investments 0
Follow on index 0.25
Exits 1
Group Appearance index 0.39

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

My Diabetes Tutor

27 Jul 2023 -

Modulo Bio

Biotechnology
Medical
Product Research
$8M01 Jun 2023 San Diego, California, United States

Eigen Therapeutics

$7M08 Dec 2022 -

GigaMune

Biotechnology
Medical
01 Nov 2022 South San Francisco, California, United States

Notable Labs

Biotechnology
Health Care
01 Jul 2022 California, United States

Foresight Mental Health

Health Care
Medical
23 Jun 2022 Berkeley, California, United States

Octant Bio

Biotechnology
Life Science
$80M28 Apr 2022 Los Angeles, California, United States

Alto Neuroscience

Artificial Intelligence
Biopharma
Neuroscience
18 Mar 2022 Los Altos, California, United States

Bionaut Labs

Biopharma
Biotechnology
Health Care
Therapeutics
16 Mar 2022 Los Angeles, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: